Table of Content

1 PDE Inhibitors Market Overview
1.1 Product Overview and Scope of PDE Inhibitors
1.2 PDE Inhibitors Segment by Type
1.2.1 Global PDE Inhibitors Market Value Comparison by Type (2024-2034)
1.2.2 PDE5
1.2.3 PDE4
1.2.4 Viagra
1.2.5 Cialis
1.2.6 Levitra
1.2.7 Others
1.3 PDE Inhibitors Segment by Application
1.3.1 Global PDE Inhibitors Market Value by Application: (2024-2034)
1.3.2 Genitourinary
1.3.3 Cardiovascular Diseases
1.3.4 Dermatological Disorders
1.3.5 Respiratory Diseases
1.3.6 Schizophrenia
1.3.7 Alzheimer’S Disease
1.3.8 Huntington’S Disease
1.3.9 Others
1.4 Global PDE Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PDE Inhibitors Revenue 2018-2034
1.4.2 Global PDE Inhibitors Sales 2018-2034
1.4.3 Global PDE Inhibitors Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 PDE Inhibitors Market Competition by Manufacturers
2.1 Global PDE Inhibitors Sales Market Share by Manufacturers (2018-2023)
2.2 Global PDE Inhibitors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PDE Inhibitors Average Price by Manufacturers (2018-2023)
2.4 Global PDE Inhibitors Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of PDE Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PDE Inhibitors, Product Type & Application
2.7 PDE Inhibitors Market Competitive Situation and Trends
2.7.1 PDE Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PDE Inhibitors Players Market Share by Revenue
2.7.3 Global PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PDE Inhibitors Retrospective Market Scenario by Region
3.1 Global PDE Inhibitors Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global PDE Inhibitors Global PDE Inhibitors Sales by Region: 2018-2034
3.2.1 Global PDE Inhibitors Sales by Region: 2018-2023
3.2.2 Global PDE Inhibitors Sales by Region: 2024-2034
3.3 Global PDE Inhibitors Global PDE Inhibitors Revenue by Region: 2018-2034
3.3.1 Global PDE Inhibitors Revenue by Region: 2018-2023
3.3.2 Global PDE Inhibitors Revenue by Region: 2024-2034
3.4 North America PDE Inhibitors Market Facts & Figures by Country
3.4.1 North America PDE Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America PDE Inhibitors Sales by Country (2018-2034)
3.4.3 North America PDE Inhibitors Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PDE Inhibitors Market Facts & Figures by Country
3.5.1 Europe PDE Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe PDE Inhibitors Sales by Country (2018-2034)
3.5.3 Europe PDE Inhibitors Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PDE Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific PDE Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific PDE Inhibitors Sales by Country (2018-2034)
3.6.3 Asia Pacific PDE Inhibitors Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PDE Inhibitors Market Facts & Figures by Country
3.7.1 Latin America PDE Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America PDE Inhibitors Sales by Country (2018-2034)
3.7.3 Latin America PDE Inhibitors Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PDE Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa PDE Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa PDE Inhibitors Sales by Country (2018-2034)
3.8.3 Middle East and Africa PDE Inhibitors Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PDE Inhibitors Sales by Type (2018-2034)
4.1.1 Global PDE Inhibitors Sales by Type (2018-2023)
4.1.2 Global PDE Inhibitors Sales by Type (2024-2034)
4.1.3 Global PDE Inhibitors Sales Market Share by Type (2018-2034)
4.2 Global PDE Inhibitors Revenue by Type (2018-2034)
4.2.1 Global PDE Inhibitors Revenue by Type (2018-2023)
4.2.2 Global PDE Inhibitors Revenue by Type (2024-2034)
4.2.3 Global PDE Inhibitors Revenue Market Share by Type (2018-2034)
4.3 Global PDE Inhibitors Price by Type (2018-2034)
5 Segment by Application
5.1 Global PDE Inhibitors Sales by Application (2018-2034)
5.1.1 Global PDE Inhibitors Sales by Application (2018-2023)
5.1.2 Global PDE Inhibitors Sales by Application (2024-2034)
5.1.3 Global PDE Inhibitors Sales Market Share by Application (2018-2034)
5.2 Global PDE Inhibitors Revenue by Application (2018-2034)
5.2.1 Global PDE Inhibitors Revenue by Application (2018-2023)
5.2.2 Global PDE Inhibitors Revenue by Application (2024-2034)
5.2.3 Global PDE Inhibitors Revenue Market Share by Application (2018-2034)
5.3 Global PDE Inhibitors Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Hanmi Science Holding
6.1.1 Hanmi Science Holding Corporation Information
6.1.2 Hanmi Science Holding Description and Business Overview
6.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hanmi Science Holding PDE Inhibitors Product Portfolio
6.1.5 Hanmi Science Holding Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim PDE Inhibitors Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Takeda Pharmaceuticals
6.3.1 Takeda Pharmaceuticals Corporation Information
6.3.2 Takeda Pharmaceuticals Description and Business Overview
6.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Takeda Pharmaceuticals PDE Inhibitors Product Portfolio
6.3.5 Takeda Pharmaceuticals Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca PDE Inhibitors Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bayer PDE Inhibitors Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Celgene
6.6.1 Celgene Corporation Information
6.6.2 Celgene Description and Business Overview
6.6.3 Celgene PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Celgene PDE Inhibitors Product Portfolio
6.6.5 Celgene Recent Developments/Updates
6.7 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly PDE Inhibitors Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer PDE Inhibitors Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 BioCrea
6.9.1 BioCrea Corporation Information
6.9.2 BioCrea Description and Business Overview
6.9.3 BioCrea PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BioCrea PDE Inhibitors Product Portfolio
6.9.5 BioCrea Recent Developments/Updates
6.10 Dart NeuroScience
6.10.1 Dart NeuroScience Corporation Information
6.10.2 Dart NeuroScience Description and Business Overview
6.10.3 Dart NeuroScience PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Dart NeuroScience PDE Inhibitors Product Portfolio
6.10.5 Dart NeuroScience Recent Developments/Updates
6.11 Carinopharm
6.11.1 Carinopharm Corporation Information
6.11.2 Carinopharm PDE Inhibitors Description and Business Overview
6.11.3 Carinopharm PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Carinopharm PDE Inhibitors Product Portfolio
6.11.5 Carinopharm Recent Developments/Updates
6.12 CTC Bio
6.12.1 CTC Bio Corporation Information
6.12.2 CTC Bio PDE Inhibitors Description and Business Overview
6.12.3 CTC Bio PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CTC Bio PDE Inhibitors Product Portfolio
6.12.5 CTC Bio Recent Developments/Updates
6.13 FORUM Pharmaceuticals
6.13.1 FORUM Pharmaceuticals Corporation Information
6.13.2 FORUM Pharmaceuticals PDE Inhibitors Description and Business Overview
6.13.3 FORUM Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.13.4 FORUM Pharmaceuticals PDE Inhibitors Product Portfolio
6.13.5 FORUM Pharmaceuticals Recent Developments/Updates
6.14 Intra-Cellular Therapies
6.14.1 Intra-Cellular Therapies Corporation Information
6.14.2 Intra-Cellular Therapies PDE Inhibitors Description and Business Overview
6.14.3 Intra-Cellular Therapies PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Intra-Cellular Therapies PDE Inhibitors Product Portfolio
6.14.5 Intra-Cellular Therapies Recent Developments/Updates
6.15 Omeros Corporation
6.15.1 Omeros Corporation Corporation Information
6.15.2 Omeros Corporation PDE Inhibitors Description and Business Overview
6.15.3 Omeros Corporation PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Omeros Corporation PDE Inhibitors Product Portfolio
6.15.5 Omeros Corporation Recent Developments/Updates
6.16 Medimetriks Pharmaceuticals
6.16.1 Medimetriks Pharmaceuticals Corporation Information
6.16.2 Medimetriks Pharmaceuticals PDE Inhibitors Description and Business Overview
6.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Product Portfolio
6.16.5 Medimetriks Pharmaceuticals Recent Developments/Updates
6.17 NuSirt Biopharma
6.17.1 NuSirt Biopharma Corporation Information
6.17.2 NuSirt Biopharma PDE Inhibitors Description and Business Overview
6.17.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.17.4 NuSirt Biopharma PDE Inhibitors Product Portfolio
6.17.5 NuSirt Biopharma Recent Developments/Updates
6.18 Palobiopharma
6.18.1 Palobiopharma Corporation Information
6.18.2 Palobiopharma PDE Inhibitors Description and Business Overview
6.18.3 Palobiopharma PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Palobiopharma PDE Inhibitors Product Portfolio
6.18.5 Palobiopharma Recent Developments/Updates
6.19 Roivant Sciences
6.19.1 Roivant Sciences Corporation Information
6.19.2 Roivant Sciences PDE Inhibitors Description and Business Overview
6.19.3 Roivant Sciences PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Roivant Sciences PDE Inhibitors Product Portfolio
6.19.5 Roivant Sciences Recent Developments/Updates
6.20 Sagene Pharmaceuticals
6.20.1 Sagene Pharmaceuticals Corporation Information
6.20.2 Sagene Pharmaceuticals PDE Inhibitors Description and Business Overview
6.20.3 Sagene Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Sagene Pharmaceuticals PDE Inhibitors Product Portfolio
6.20.5 Sagene Pharmaceuticals Recent Developments/Updates
6.21 Tetra Discovery Partners
6.21.1 Tetra Discovery Partners Corporation Information
6.21.2 Tetra Discovery Partners PDE Inhibitors Description and Business Overview
6.21.3 Tetra Discovery Partners PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Tetra Discovery Partners PDE Inhibitors Product Portfolio
6.21.5 Tetra Discovery Partners Recent Developments/Updates
6.22 Tritech Biopharm
6.22.1 Tritech Biopharm Corporation Information
6.22.2 Tritech Biopharm PDE Inhibitors Description and Business Overview
6.22.3 Tritech Biopharm PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Tritech Biopharm PDE Inhibitors Product Portfolio
6.22.5 Tritech Biopharm Recent Developments/Updates
6.23 Otsuka
6.23.1 Otsuka Corporation Information
6.23.2 Otsuka PDE Inhibitors Description and Business Overview
6.23.3 Otsuka PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Otsuka PDE Inhibitors Product Portfolio
6.23.5 Otsuka Recent Developments/Updates
6.24 Chiesi Farmaceutici
6.24.1 Chiesi Farmaceutici Corporation Information
6.24.2 Chiesi Farmaceutici PDE Inhibitors Description and Business Overview
6.24.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Chiesi Farmaceutici PDE Inhibitors Product Portfolio
6.24.5 Chiesi Farmaceutici Recent Developments/Updates
6.25 Verona Pharma
6.25.1 Verona Pharma Corporation Information
6.25.2 Verona Pharma PDE Inhibitors Description and Business Overview
6.25.3 Verona Pharma PDE Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Verona Pharma PDE Inhibitors Product Portfolio
6.25.5 Verona Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PDE Inhibitors Industry Chain Analysis
7.2 PDE Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PDE Inhibitors Production Mode & Process
7.4 PDE Inhibitors Sales and Marketing
7.4.1 PDE Inhibitors Sales Channels
7.4.2 PDE Inhibitors Distributors
7.5 PDE Inhibitors Customers
8 PDE Inhibitors Market Dynamics
8.1 PDE Inhibitors Industry Trends
8.2 PDE Inhibitors Market Drivers
8.3 PDE Inhibitors Market Challenges
8.4 PDE Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global PDE Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global PDE Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global PDE Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global PDE Inhibitors Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global PDE Inhibitors Sales Market Share by Manufacturers (2018-2023)
Table 6. Global PDE Inhibitors Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global PDE Inhibitors Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market PDE Inhibitors Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of PDE Inhibitors, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of PDE Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PDE Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of PDE Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDE Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDE Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDE Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global PDE Inhibitors Sales by Region (2018-2023) & (K Units)
Table 18. Global PDE Inhibitors Sales Market Share by Region (2018-2023)
Table 19. Global PDE Inhibitors Sales by Region (2024-2034) & (K Units)
Table 20. Global PDE Inhibitors Sales Market Share by Region (2024-2034)
Table 21. Global PDE Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global PDE Inhibitors Revenue Market Share by Region (2018-2023)
Table 23. Global PDE Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global PDE Inhibitors Revenue Market Share by Region (2024-2034)
Table 25. North America PDE Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America PDE Inhibitors Sales by Country (2018-2023) & (K Units)
Table 27. North America PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 28. North America PDE Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America PDE Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe PDE Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe PDE Inhibitors Sales by Country (2018-2023) & (K Units)
Table 32. Europe PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 33. Europe PDE Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe PDE Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific PDE Inhibitors Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific PDE Inhibitors Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific PDE Inhibitors Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific PDE Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific PDE Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America PDE Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America PDE Inhibitors Sales by Country (2018-2023) & (K Units)
Table 42. Latin America PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 43. Latin America PDE Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America PDE Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa PDE Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa PDE Inhibitors Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa PDE Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa PDE Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global PDE Inhibitors Sales (K Units) by Type (2018-2023)
Table 51. Global PDE Inhibitors Sales (K Units) by Type (2024-2034)
Table 52. Global PDE Inhibitors Sales Market Share by Type (2018-2023)
Table 53. Global PDE Inhibitors Sales Market Share by Type (2024-2034)
Table 54. Global PDE Inhibitors Revenue (US$ Million) by Type (2018-2023)
Table 55. Global PDE Inhibitors Revenue (US$ Million) by Type (2024-2034)
Table 56. Global PDE Inhibitors Revenue Market Share by Type (2018-2023)
Table 57. Global PDE Inhibitors Revenue Market Share by Type (2024-2034)
Table 58. Global PDE Inhibitors Price (USD/Unit) by Type (2018-2023)
Table 59. Global PDE Inhibitors Price (USD/Unit) by Type (2024-2034)
Table 60. Global PDE Inhibitors Sales (K Units) by Application (2018-2023)
Table 61. Global PDE Inhibitors Sales (K Units) by Application (2024-2034)
Table 62. Global PDE Inhibitors Sales Market Share by Application (2018-2023)
Table 63. Global PDE Inhibitors Sales Market Share by Application (2024-2034)
Table 64. Global PDE Inhibitors Revenue (US$ Million) by Application (2018-2023)
Table 65. Global PDE Inhibitors Revenue (US$ Million) by Application (2024-2034)
Table 66. Global PDE Inhibitors Revenue Market Share by Application (2018-2023)
Table 67. Global PDE Inhibitors Revenue Market Share by Application (2024-2034)
Table 68. Global PDE Inhibitors Price (USD/Unit) by Application (2018-2023)
Table 69. Global PDE Inhibitors Price (USD/Unit) by Application (2024-2034)
Table 70. Hanmi Science Holding Corporation Information
Table 71. Hanmi Science Holding Description and Business Overview
Table 72. Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Hanmi Science Holding PDE Inhibitors Product
Table 74. Hanmi Science Holding Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Boehringer Ingelheim PDE Inhibitors Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Takeda Pharmaceuticals Corporation Information
Table 81. Takeda Pharmaceuticals Description and Business Overview
Table 82. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Takeda Pharmaceuticals PDE Inhibitors Product
Table 84. Takeda Pharmaceuticals Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca PDE Inhibitors Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Bayer PDE Inhibitors Product
Table 94. Bayer Recent Developments/Updates
Table 95. Celgene Corporation Information
Table 96. Celgene Description and Business Overview
Table 97. Celgene PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Celgene PDE Inhibitors Product
Table 99. Celgene Recent Developments/Updates
Table 100. Eli Lilly Corporation Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Eli Lilly PDE Inhibitors Product
Table 104. Eli Lilly Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Pfizer PDE Inhibitors Product
Table 109. Pfizer Recent Developments/Updates
Table 110. BioCrea Corporation Information
Table 111. BioCrea Description and Business Overview
Table 112. BioCrea PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. BioCrea PDE Inhibitors Product
Table 114. BioCrea Recent Developments/Updates
Table 115. Dart NeuroScience Corporation Information
Table 116. Dart NeuroScience Description and Business Overview
Table 117. Dart NeuroScience PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Dart NeuroScience PDE Inhibitors Product
Table 119. Dart NeuroScience Recent Developments/Updates
Table 120. Carinopharm Corporation Information
Table 121. Carinopharm Description and Business Overview
Table 122. Carinopharm PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Carinopharm PDE Inhibitors Product
Table 124. Carinopharm Recent Developments/Updates
Table 125. CTC Bio Corporation Information
Table 126. CTC Bio Description and Business Overview
Table 127. CTC Bio PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. CTC Bio PDE Inhibitors Product
Table 129. CTC Bio Recent Developments/Updates
Table 130. FORUM Pharmaceuticals Corporation Information
Table 131. FORUM Pharmaceuticals Description and Business Overview
Table 132. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. FORUM Pharmaceuticals PDE Inhibitors Product
Table 134. FORUM Pharmaceuticals Recent Developments/Updates
Table 135. Intra-Cellular Therapies Corporation Information
Table 136. Intra-Cellular Therapies Description and Business Overview
Table 137. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Intra-Cellular Therapies PDE Inhibitors Product
Table 139. Intra-Cellular Therapies Recent Developments/Updates
Table 140. Omeros Corporation Corporation Information
Table 141. Omeros Corporation Description and Business Overview
Table 142. Omeros Corporation PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Omeros Corporation PDE Inhibitors Product
Table 144. Omeros Corporation Recent Developments/Updates
Table 145. Medimetriks Pharmaceuticals Corporation Information
Table 146. Medimetriks Pharmaceuticals Description and Business Overview
Table 147. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Medimetriks Pharmaceuticals PDE Inhibitors Product
Table 149. Medimetriks Pharmaceuticals Recent Developments/Updates
Table 150. NuSirt Biopharma Corporation Information
Table 151. NuSirt Biopharma Description and Business Overview
Table 152. NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. NuSirt Biopharma PDE Inhibitors Product
Table 154. NuSirt Biopharma Recent Developments/Updates
Table 155. Palobiopharma Corporation Information
Table 156. Palobiopharma Description and Business Overview
Table 157. Palobiopharma PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Palobiopharma PDE Inhibitors Product
Table 159. Palobiopharma Recent Developments/Updates
Table 160. Roivant Sciences Corporation Information
Table 161. Roivant Sciences Description and Business Overview
Table 162. Roivant Sciences PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Roivant Sciences PDE Inhibitors Product
Table 164. Roivant Sciences Recent Developments/Updates
Table 165. Sagene Pharmaceuticals Corporation Information
Table 166. Sagene Pharmaceuticals Description and Business Overview
Table 167. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. Sagene Pharmaceuticals PDE Inhibitors Product
Table 169. Sagene Pharmaceuticals Recent Developments/Updates
Table 170. Tetra Discovery Partners Corporation Information
Table 171. Tetra Discovery Partners Description and Business Overview
Table 172. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 173. Tetra Discovery Partners PDE Inhibitors Product
Table 174. Tetra Discovery Partners Recent Developments/Updates
Table 175. Tritech Biopharm Corporation Information
Table 176. Tritech Biopharm Description and Business Overview
Table 177. Tritech Biopharm PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 178. Tritech Biopharm PDE Inhibitors Product
Table 179. Tritech Biopharm Recent Developments/Updates
Table 180. Otsuka Corporation Information
Table 181. Otsuka Description and Business Overview
Table 182. Otsuka PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 183. Otsuka PDE Inhibitors Product
Table 184. Otsuka Recent Developments/Updates
Table 185. Chiesi Farmaceutici Corporation Information
Table 186. Chiesi Farmaceutici Description and Business Overview
Table 187. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 188. Chiesi Farmaceutici PDE Inhibitors Product
Table 189. Chiesi Farmaceutici Recent Developments/Updates
Table 190. Verona Pharma Corporation Information
Table 191. Verona Pharma Description and Business Overview
Table 192. Verona Pharma PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 193. Verona Pharma PDE Inhibitors Product
Table 194. Verona Pharma Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. PDE Inhibitors Distributors List
Table 198. PDE Inhibitors Customers List
Table 199. PDE Inhibitors Market Trends
Table 200. PDE Inhibitors Market Drivers
Table 201. PDE Inhibitors Market Challenges
Table 202. PDE Inhibitors Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PDE Inhibitors
Figure 2. Global PDE Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global PDE Inhibitors Market Share by Type in 2024 & 2034
Figure 4. PDE5 Product Picture
Figure 5. PDE4 Product Picture
Figure 6. Viagra Product Picture
Figure 7. Cialis Product Picture
Figure 8. Levitra Product Picture
Figure 9. Others Product Picture
Figure 10. Global PDE Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global PDE Inhibitors Market Share by Application in 2024 & 2034
Figure 12. Genitourinary
Figure 13. Cardiovascular Diseases
Figure 14. Dermatological Disorders
Figure 15. Respiratory Diseases
Figure 16. Schizophrenia
Figure 17. Alzheimer’S Disease
Figure 18. Huntington’S Disease
Figure 19. Others
Figure 20. Global PDE Inhibitors Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 21. Global PDE Inhibitors Market Size (2018-2034) & (US$ Million)
Figure 22. Global PDE Inhibitors Sales (2018-2034) & (K Units)
Figure 23. Global PDE Inhibitors Average Price (USD/Unit) & (2018-2034)
Figure 24. PDE Inhibitors Report Years Considered
Figure 25. PDE Inhibitors Sales Share by Manufacturers in 2024
Figure 26. Global PDE Inhibitors Revenue Share by Manufacturers in 2024
Figure 27. The Global 5 and 10 Largest PDE Inhibitors Players: Market Share by Revenue in 2024
Figure 28. PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 29. Global PDE Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 30. North America PDE Inhibitors Sales Market Share by Country (2018-2034)
Figure 31. North America PDE Inhibitors Revenue Market Share by Country (2018-2034)
Figure 32. U.S. PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Canada PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Europe PDE Inhibitors Sales Market Share by Country (2018-2034)
Figure 35. Europe PDE Inhibitors Revenue Market Share by Country (2018-2034)
Figure 36. Germany PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. France PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. U.K. PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Italy PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Russia PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Asia Pacific PDE Inhibitors Sales Market Share by Region (2018-2034)
Figure 42. Asia Pacific PDE Inhibitors Revenue Market Share by Region (2018-2034)
Figure 43. China PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Japan PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. South Korea PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. India PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Australia PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. China Taiwan PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Indonesia PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Thailand PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Malaysia PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Latin America PDE Inhibitors Sales Market Share by Country (2018-2034)
Figure 53. Latin America PDE Inhibitors Revenue Market Share by Country (2018-2034)
Figure 54. Mexico PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Brazil PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Argentina PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East & Africa PDE Inhibitors Sales Market Share by Country (2018-2034)
Figure 58. Middle East & Africa PDE Inhibitors Revenue Market Share by Country (2018-2034)
Figure 59. Turkey PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Saudi Arabia PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 61. UAE PDE Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 62. Global Sales Market Share of PDE Inhibitors by Type (2018-2034)
Figure 63. Global Revenue Market Share of PDE Inhibitors by Type (2018-2034)
Figure 64. Global PDE Inhibitors Price (USD/Unit) by Type (2018-2034)
Figure 65. Global Sales Market Share of PDE Inhibitors by Application (2018-2034)
Figure 66. Global Revenue Market Share of PDE Inhibitors by Application (2018-2034)
Figure 67. Global PDE Inhibitors Price (USD/Unit) by Application (2018-2034)
Figure 68. PDE Inhibitors Value Chain
Figure 69. PDE Inhibitors Production Process
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Distributors Profiles
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed